Using qualitative methods to inform the trade-off between content validity and consistency in utility assessment: The example of type 2 diabetes and Alzheimer's Disease

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  Mcgrath, Clare ^a   Rofail, Diana ^b   Gargon, Elizabeth ^b   Abetz, Linda ^b  

^a Health Technology Assessment Policy   (United Kingdom)

^b ADELPHI REAL WORLD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTENT VALIDITY; DECISION MAKING; EUROQOL 5 DIMENSIONS; HEALTH UTILITIES INDEX 3; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITATIVE RESEARCH; QUALITY OF LIFE; QUANTITATIVE STUDY; SCORING SYSTEM; STATISTICAL MODEL; ADOLESCENT; CHILD; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; HEALTH STATUS; METHODOLOGY; OUTCOME ASSESSMENT; QUALITY ADJUSTED LIFE YEAR; RESOURCE ALLOCATION; REVIEW; STANDARD;

ADOLESCENT; ALZHEIMER DISEASE; CHILD; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DIABETES MELLITUS, TYPE 2; HEALTH STATUS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITATIVE RESEARCH; QUALITY-ADJUSTED LIFE YEARS; RESOURCE ALLOCATION;

EID: 77949445041     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-23     Document Type: Article

References (72)

1. Ryan M, Scott DA, Reeves C, Bate A, van Teijlingen ER, Russell EM, et al. Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess 2001, 5:1-186.
2. Brauer CA, Neumann PJ. Quality-adjusted life years: how useful in medico economic studies. Fundam Clin Pharmacol 2005, 19:603-607. 10.1111/j.1472-8206.2005.00369.x, 16313271.
3. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal 2008,
4. Scottish Medicines Consortium Guidance to Manufacturers for Completion of New Product Assessment Form (NPAF) (Revised June 2007). Scottish Medicines Consortium.
5. General guidelines for economic evaluations from the Pharmaceutical Benefits Board. 2003, 1-3.
6. Guidelines for pharmaco economic research, updated version. 2006, College voor zorgverzekeringen, Diemen.
7. Canadian Agency for Drugs and Technologies in Health 2006, Guidelines for the Economic Evaluation of Health Technologies: Canada, Canadian Agency for Drugs and Technologies in Health.
8. Quality-adjusted life-years (QALYs). The Health Economics Handbook 2000, 140. Kielhorn A, Schulenburg J.
9. Dolan P. Output measures and valuation in health. Economic evaluation in health care 2001, 47-67. Oxford: Oxford University Press, Drummond M, McGuire A.
10. Feeny DH, Furlong W, Boyle M, Torrance GW. Health Utilities Index. Quality of Life and Pharmacoeconomics in Clinical Trials 1996, 85-95. Philadelphia: Lipponcott-Raven Press, Spilker B.
11. Sintonen H. The 15D-measure of health related quality of life. I. Reliability, validity and sensitivity of its health state descriptive system. National Centre for Health Program Evaluation 1994, Working paper 41..
12. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Medical care 2004, 42:851-859. 10.1097/01.mlr.0000135827.18610.0d, 15319610.
13. EuroQol Group EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. 10.1016/0168-8510(90)90421-9, 10109801, EuroQol Group.
14. Arnould B. Patient-Reported Outcomes and Clinical Practice. From measurement Instruments to decision Tools: Much More than a Simple Change in Format. PRO Newsletter 2006, 36:21-24.
15. Guyatt GH, Jaeschke R. Quality of Life Assessments in Clinical Trials (Chapter 4). Quality of Life Assessments in Clinical Trials 1990, 43. Spilker B.
16. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Center for Devices and Radiological Health (CDRH) Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2006, U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Center for Devices and Radiological Health (CDRH).
17. European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. 2005, European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use.
18. Johnson FR. Editorial: Moving the QALY Forward or Just Stuck in Traffic?. Value in Health 2009, 12:S38-S39. 10.1111/j.1524-4733.2009.00521.x, 19250131.
19. Kind P, Lafata JE, Matuszewski K, Raisch D. The use of QLYs in clinical an d patient decision-making: issues and prospects. Value in Health 2009, 12:S27-S30. 10.1111/j.1524-4733.2009.00519.x, 19250128.
20. Smith MD, Drummond M, Brixner D. Moving the QALY Forward: Rationale for Change. Value in Health 2009, 12:S1-S4.
21. Drummond M, Brixner D, Gold M, Kind P, McGuire A, Nord E. Toward a Consensus on the QALY. Value in Health 2009, 12:S31-S35. 10.1111/j.1524-4733.2009.00522.x, 19250129.
22. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology 2006, 3:77-101.
23. Phinney A, Wallhagen M. Recognizing and understanding the symptoms of type 2 diabetes. The Canadian journal of nursing research 2003, 35:108-124.
24. Elstad E, Tusiofo C, Rosen R, McGarvey S. Living with Ma'i Suka: individual, familial, cultural, and environmental stress among patients with type 2 diabetes mellitus and their caregivers in American Samoa. Preventing chronic disease 2008, 5:A79. 2483557, 18558029.
25. Hill B, Cooper D, Loman K, Brancati F, Cooper L. A qualitative study of problem solving and diabetes control in type 2 diabetes self-management. The Diabetes educator 2003, 29:1018-1028. 10.1177/014572170302900612, 14692375.
26. Koopman R, Mainous, Jeffcoat A. Moving from undiagnosed to diagnosed diabetes: The patient's perspective. Fam Med 2004, 36:727-732.
27. Adams C. Lessons learned from urban Latinas with type 2 diabetes mellitus. Journal of transcultural nursing: official journal of theTranscultural Nursing Society/Transcultural Nursing Society 2003, 14:255-265.
28. Lawton J, Ahmad N, Hanna L, Douglas M, Hallowell N. Diabetes service provision: a qualitative study of the experiences and views of Pakistani and Indian patients with Type 2 diabetes. Diabetic medicine: a journal of the British Diabetic Association 2006, 23:1003-1007.
29. Carter E, Skelly A, Cagle C, Appel S. They care but don't understand: family support of African American women with type 2 diabetes. The Diabetes educator 2004, 30:493-501. 10.1177/014572170403000321, 15208847.
30. Heuer L, Lausch C. Living with diabetes: perceptions of Hispanic migrant farmworkers. Journal of community health nursing 2006, 23:49-64. 10.1207/s15327655jchn2301_5, 16445364.
31. Penckofer S, Ferrans C, Velsor F, Savoy S. The psychological impact of living with diabetes: women's day-to-day experiences. The Diabetes educator 2007, 33:680-690. 10.1177/0145721707304079, 17684169.
32. Morrow A, Haidet P, Skinner J, Naik A. Integrating diabetes self-management with the health goals of older adults: A qualitative exploration. Patient education and counseling 2008, 72:418-423. 10.1016/j.pec.2008.05.017, 2613855, 18621501.
33. Lawton J, Peel E, Parry O, Douglas M. Patients' perceptions and experiences of taking oral glucose-lowering agents: A longitudinal qualitative study. Diabetic Med 2008, 25:491-495. 10.1111/j.1464-5491.2008.02400.x, 18294222.
34. Burke J, Earley M, Dixon L, Wilke A, Puczynski S. Patients With Diabetes Speak: Exploring the Implications of Patients' Perspectives for Their Diabetes Appointments. Health communication 2006, 19:103-114. 10.1207/s15327027hc1902_2, 16548701.
35. Nagelkerk J, Reick K, Meengs L. Perceived barriers and effective strategies to diabetes self-management. J-Adv-Nurs 2006, 54:151-158. 10.1111/j.1365-2648.2006.03799.x, 16553701.
36. Lawton J, Ahmad N, Hanna L, Douglas M, Hallowell N. 'I can't do any serious exercise': barriers to physical activity amongst people of Pakistani and Indian origin with Type 2 diabetes. Health-Educ-Res 2006, 21:43-54. 10.1093/her/cyh042, 15955792.
37. Kokanovic R, Manderson L. Exploring doctor-patient communication in immigrant Australians with type 2 diabetes: a qualitative study. Journal of general internal medicine: official journal of the Societyfor Research and Education in Primary Care Internal Medicine 2007, 22:459-463.
38. Mulvaney S, Mudasiru E, Schlundt D, Baughman C, Fleming M, VanderWoude A, et al. Self-management in type 2 diabetes: the adolescent perspective. The Diabetes educator 2008, 34:674-682. 10.1177/0145721708320902, 2757076, 18669809.
39. Peel E, Parry O, Douglas M, Lawton J. Diagnosis of type 2 diabetes: a qualitative analysis of patients' emotional reactions and views about information provision. Patient education and counseling 2004, 53:269-275. 10.1016/j.pec.2003.07.010, 15186863.
40. Brown K, Avis M, Hubbard M. Health beliefs of African-Caribbean people with type 2 diabetes: A qualitative study. Br J Gen Pract 2007, 57:461-469. 2078187, 17550671.
41. DeCoster V. The emotions of adults with diabetes: A comparison across race. Social work in health care 2003, 36:79-99. 10.1300/J010v36n04_05, 12836781.
42. Rockliffe F, Kiemle G. Sexual function in diabetic women: A psychological perspective. Sex Relatsh Ther 2003, 18:143-159.
43. Mier N, Medina A, Ory M. Mexican Americans with type 2 diabetes: perspectives on definitions, motivators, and programs of physical activity. Preventing chronic disease 2007, 4:A24. 1893123, 17362615.
44. Liburd L, Namageyo F, Jack J. Understanding "masculinity" and the challenges of managing type-2 diabetes among African-American men. J Natl Med Assoc 2007, 99:550-558. 2576079, 17534013.
45. Gorawara B, Huang E, Chin M. Communicating with older diabetes patients: Self-management and social comparison. Patient education and counseling 2008, 72:411-417. 10.1016/j.pec.2008.05.011, 18639997.
46. Smith SM, Leary M, Bury G, Shannon W, Tynan A, Staines A, et al. A qualitative investigation of the views and health beliefs of patients with Type 2 diabetes following the introduction of a diabetes shared care service. Diabetic medicine: a journal of the British Diabetic Association 2003, 20:853-857.
47. Sarkadi A, Rosenqvist U. Intimacy and women with type 2 diabetes: an exploratory study using focus group interviews. The Diabetes educator 2003, 29:641-652. 10.1177/014572170302900410, 13677175.
48. Bolanos E, Sarria S. Perspective of patients on type-2 diabetes and their relationship with primary care health professionals: A qualitative study. Aten Prim 2003, 32:195-201.
49. Vinter R, Petricek G, Katic M. Obstacles which patients with type 2 diabetes meet while adhering to the therapeutic regimen in everyday life: qualitative study. Croatian medical journal 2004, 45:630-636.
50. Broom D, Whittaker A. Controlling diabetes, controlling diabetics: moral language in the management of diabetes type 2. Social science & medicine (1982) 2004, 58:2371-2382.
51. Bogatean M, Hancu N. People with type 2 diabetes facing the reality of starting insulin therapy: Factors involved in psychological insulin resistance. Pract Diabetes Int 2004, 21:247-252.
52. Huang E, Gorawara B, Chin M. Self-Reported Goals of Older Patients with Type 2 Diabetes Mellitus. Journal of the American Geriatrics Society 2005, 53:306-311. 10.1111/j.1532-5415.2005.53119.x, 2291346, 15673357.
53. Morris J, Povey RC, Street CG. Experiences of people with type 2 diabetes who have changed from oral medication to self-administered insulin injections. A qualitative study. Pract Diabetes Int 2005, 22:239-243.
54. Hayes R, Bowman L, Monahan P, Marrero D, Mc Horney C. Understanding diabetes medications from the perspective of patients with type 2 diabetes: prerequisite to medication concordance. The Diabetes educator 2006, 32:404-414. 10.1177/0145721706288182, 16772656.
55. de Alba Garcia JG, Salcedo Rocha A, Lopez I, Baer R, Dressler W, Weller S. "Diabetes is my companion": Lifestyle and self-management among good and poor control Mexican diabetic patients. Soc Sci Med 2007, 64:2223-2235. 10.1016/j.socscimed.2007.02.001, 17383785.
56. Yamakawa M, Makimoto K. Positive experiences of type 2 diabetes in Japanese patients: an exploratory qualitative study. Int-J-Nurs-Stud 2008, 45:1032-1041. 10.1016/j.ijnurstu.2007.05.003, 17568586.
57. Peel E, Parry O, Douglas M, Lawton J. Blood glucose self-monitoring in non-insulin-treated type 2 diabetes: a qualitative study of patients' perspectives. The British journal of general practice: the journal of the RoyalCollege of General Practitioners 2004, 54:183-188.
58. Alazri M, Neal R, Heywood P, Leese B. Patient's experiences of continuity in the care of type 2 diabetes: A focus group study in primary care. Br J Gen Pract 2006, 56:488-495. 1872058, 16834874.
59. Clare L. Managing threats to self: awareness in early stage Alzheimer's disease. Social science & medicine (1982) 2003, 57:1017-1029.
60. Ohman A, Nygard L. Meanings and motives for engagement in self-chosen daily life occupations among individuals with Alzheimer's disease. OTJR Occup Part Health 2005, 25:89-97.
61. MacQuarrie C. Experiences in early stage Alzheimer's disease: Understanding the paradox of acceptance and denial. Aging Ment Health 2005, 9:430-441. 10.1080/13607860500142853, 16024402.
62. Daniels K, Lamson A, Hodgson J. An Exploration of the Marital Relationship and Alzheimer's Disease: One Couple's Story. Fam Syst Health 2007, 25:162-177.
63. Parsons S, Johnson M, McCann J, Solberg S. Losing one's memory in early Alzheimer's disease. Qualitative health research 2008, 18:31-42. 10.1177/1049732307308987, 18174533.
64. Clare L, Roth I, Pratt R. Perceptions of change over time in early-stage Alzheimer's disease: Implications for understanding awareness and coping style. Dementia: The International Journal of Social Research and Practice 2005, 4:487-520.
65. Ohman A, Josephsson S, Nygord L. Awareness through interaction in everyday occupations: experiences of people with Alzheimer's disease. Scandinavian journal of occupational therapy 2008, 15:43-51. 10.1080/11038120701441080, 17852957.
66. Harman G, Clare L. Illness representations and lived experience in early-stage dementia. Qualitative health research 2006, 16:484-502. 10.1177/1049732306286851, 16513992.
67. Keady J, Williams S, Hughes R. 'Making mistakes': Using co-constructed inquiry to illuminate meaning and relationships in the early adjustment to Alzheimer's disease--a single case study approach. Dementia: The International Journal of Social Research and Practice 2007, 6:343-364.
68. Beard R, Fox P. Resisting social disenfranchisement: Negotiating collective identities and everyday life with memory loss. Soc Sci Med 2008, 66:1509-1520. 10.1016/j.socscimed.2007.12.024, 18222581.
69. Brazier J, Ratcliffe J, Salomon JA, Tsuchiya A. Methods for obtaining health state values: generic preference-based measures of health and the alternatives. Measuring and Valuing Health Benefits for Economic Evaluation 2007, 175-239.
70. Espallargues M, Czoski-Murray CJ, Bansback NJ, Carlton J, Lewis GM, Hughes LA, et al. The Impact of Age-Related Macular Degeneration on Health Status Utility Values. Investigative Opthalmology and Visual Science 2005, 46:4016-4023.
71. Kontodimopoulos N, Pappa E, Papadopoulos A, Tountas Y, Niakas D. Comparing SF-6D and EQ-5D utilities across groups differing in health status. Quality of Life Research 2009, 18:87-97. 10.1007/s11136-008-9420-8, 19051058.
72. McDonough C, Tosteson A. Measuring preferences for cost-utility analysis: how choice of method may influence decision-making. Pharmacoeconomics 2007, 25:93-106. 10.2165/00019053-200725020-00003, 17249853.